What is the appropriate workup for a 38-year-old male with treated hypertension, normal hemoglobin A1c, elevated urine albumin‑to‑creatinine ratio, normal serum creatinine and estimated glomerular filtration rate, and high triglycerides and low‑density lipoprotein cholesterol?

Workup for 38-Year-Old Male with Treated HTN, Normal A1c, Elevated UACR, Normal Serum Cr/GFR, and Dyslipidemia

This patient requires immediate evaluation for secondary causes of hypertension and early kidney disease, with urgent optimization of his antihypertensive regimen to include an ACE inhibitor or ARB, given his elevated UACR indicating kidney damage despite normal GFR.

Immediate Diagnostic Workup

Confirm and Quantify Albuminuria

• Repeat UACR measurement on two additional first morning void specimens within 3-6 months to confirm persistent albuminuria, as biological variability exceeds 20% between measurements 1
• Two of three specimens must be abnormal (≥30 mg/g) to confirm elevated urinary albumin excretion 1
• Ensure patient is well-hydrated, has not exercised within 24 hours, and has no concurrent infection, fever, or marked hyperglycemia, as these can falsely elevate UACR 1

Assess for Secondary Hypertension

Given this patient's young age (38 years) with treated hypertension and now kidney involvement, evaluate for:

• Renal artery stenosis: Order renal artery duplex ultrasound or CT/MR angiography
• Primary aldosteronism: Measure plasma aldosterone concentration and plasma renin activity (aldosterone-to-renin ratio)
• Pheochromocytoma: 24-hour urine metanephrines if clinically indicated
• Sleep apnea: Screen with validated questionnaire and consider polysomnography

Evaluate Kidney Structure and Function

• Renal ultrasound to assess kidney size, echogenicity, and rule out structural abnormalities 2
• Serum potassium and creatinine at baseline and periodically when adjusting medications 1, 3
• Urinalysis with microscopy to evaluate for hematuria, casts, or other signs suggesting glomerular disease beyond diabetic/hypertensive nephropathy 1

Cardiovascular Risk Assessment

• Carotid intima-media thickness (IMT) ultrasound to detect early atherosclerotic changes, as this patient has multiple cardiovascular risk factors 2
• Echocardiography to assess for left ventricular hypertrophy and diastolic dysfunction, both common in hypertensive patients with albuminuria 2
• Ankle-brachial index to screen for peripheral arterial disease 2

Lipid Panel Optimization

• Fasting lipid panel including total cholesterol, LDL-C, HDL-C, triglycerides, and non-HDL cholesterol
• Calculate 10-year atherosclerotic cardiovascular disease (ASCVD) risk score

Critical Management Considerations

Antihypertensive Medication Adjustment

The patient MUST be on an ACE inhibitor or ARB at maximum tolerated dose given his elevated UACR, regardless of whether he has diabetes 1, 3. This is strongly recommended (Grade A evidence) for UACR ≥30 mg/g to reduce progressive kidney disease risk 1, 3.

• If already on ACE-I/ARB, titrate to maximum tolerated dose indicated for blood pressure treatment 3
• Monitor serum creatinine and potassium 1-2 weeks after initiation or dose increase 1, 3
• Do not discontinue if creatinine increases ≤30% without volume depletion 1
• Target blood pressure <130/80 mmHg 4, 5

Lipid Management

Given elevated triglycerides, LDL, and albuminuria (which increases cardiovascular risk):

• Initiate high-intensity statin therapy (atorvastatin 40-80 mg or rosuvastatin 20-40 mg)
• Consider adding icosapent ethyl if triglycerides remain ≥150 mg/dL on statin
• Target LDL-C <70 mg/dL given high cardiovascular risk from albuminuria 6, 7

Monitoring Strategy

• Repeat UACR every 6 months to assess treatment response 1
• A 30% reduction in UACR from baseline is the therapeutic goal, as this correlates with reduced cardiovascular and kidney events 6
• Annual monitoring of serum creatinine/eGFR and potassium 1, 3

Common Pitfalls to Avoid

1. Don't assume normal serum creatinine means no kidney disease: This patient has clear evidence of kidney damage (elevated UACR) despite normal GFR—this is early chronic kidney disease 1, 8

2. Don't delay ACE-I/ARB therapy: Even with "modestly elevated" UACR (30-299 mg/g), ACE-I/ARB is recommended (Grade B), and strongly recommended if UACR ≥300 mg/g 1, 3

3. Don't use random spot UACR for monitoring: First morning void is preferred to minimize variability 9, 1

4. Don't overlook secondary hypertension: Young age with end-organ damage warrants thorough evaluation for reversible causes

5. Don't ignore the lipid-albuminuria connection: Elevated triglycerides are independently associated with increased UACR and worsen kidney disease progression 10, 11, 12

Nephrology Referral Criteria

Promptly refer to nephrology if 1:

• Uncertainty about etiology of kidney disease (given young age and absence of diabetes)
• Rapidly progressive kidney disease
• Difficulty achieving blood pressure or UACR targets
• eGFR declines to <60 mL/min/1.73 m² (though not currently present)

The combination of young age, hypertension, albuminuria, and dyslipidemia suggests this patient may have an underlying glomerular disease or secondary cause requiring specialist evaluation sooner rather than later.